OptimizeRx Co. (NASDAQ:OPRX) Sees Large Decline in Short Interest
OptimizeRx Co. (NASDAQ:OPRX) saw a significant decrease in short interest in the month of January. As of January 31st, there was short interest totalling 734,200 shares, a decrease of 13.2% from the January 15th total of 845,500 shares. Based on an average daily volume of 107,800 shares, the days-to-cover ratio is currently 6.8 days. Approximately 6.4% of the company’s stock are short sold.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Citigroup Inc. raised its position in OptimizeRx by 304.2% in the 4th quarter. Citigroup Inc. now owns 2,765 shares of the company’s stock valued at $28,000 after buying an additional 2,081 shares during the last quarter. Barclays PLC grew its stake in OptimizeRx by 34.7% in the 3rd quarter. Barclays PLC now owns 10,403 shares of the company’s stock valued at $151,000 after purchasing an additional 2,678 shares during the period. California State Teachers Retirement System grew its stake in OptimizeRx by 16.5% in the 3rd quarter. California State Teachers Retirement System now owns 21,500 shares of the company’s stock valued at $311,000 after purchasing an additional 3,049 shares during the period. UBS Group AG grew its stake in OptimizeRx by 34.9% in the 4th quarter. UBS Group AG now owns 17,000 shares of the company’s stock valued at $175,000 after purchasing an additional 4,397 shares during the period. Finally, Squarepoint Ops LLC grew its stake in OptimizeRx by 25.0% in the 3rd quarter. Squarepoint Ops LLC now owns 27,000 shares of the company’s stock valued at $391,000 after purchasing an additional 5,400 shares during the period. 61.22% of the stock is owned by institutional investors and hedge funds.
NASDAQ OPRX traded down $0.13 on Friday, reaching $10.58. The company had a trading volume of 12,403 shares, compared to its average volume of 68,458. The stock has a market capitalization of $149.96 million, a P/E ratio of -117.56 and a beta of 0.31. The company’s fifty day moving average is $10.46 and its 200 day moving average is $12.43. OptimizeRx has a 52-week low of $8.63 and a 52-week high of $17.24. The company has a quick ratio of 7.00, a current ratio of 7.00 and a debt-to-equity ratio of 0.01.
OptimizeRx Company Profile
OptimizeRx Corporation provides digital health messaging services for pharmaceutical companies to communicate with healthcare providers. The company's cloud-based solutions support patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and critical clinical information; and network consists of electronic health records platforms, which provide the ambulatory patient market with access to their workflow at the point-of-care.
Read More: Guidelines for Successful Channel Trading
Receive News & Ratings for OptimizeRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptimizeRx and related companies with MarketBeat.com's FREE daily email newsletter.